PLASIL 5mg|5ml Syrup 50ml

 17.48

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 5mg/5ml
Drug Form : Syrup
Pack Size : 50ml
Does this requires a prescription ?Yes

Metoclopramide (HCl):5mg/5ml | Antiemetics & antinauseants

Alternate brands

  • METOPRIDE 5mg|5ml Syrup 50ml
     29.00
  • You will pay -11.52 more
  • METOCLOP 5mg|5ml Syrup 50ml
     14.00
  • You can save 3.48
  • METOCA 5mg|5ml Syrup 50ml
     15.00
  • You can save 2.48
  • METOCARE 5mg|5ml Syrup 50ml
     15.00
  • You can save 2.48
  • M-CLON 5mg|5ml Syrup 50ml
     14.00
  • You can save 3.48

    Manufactured / Marketed By : Pacific Product Form : SyrupPack Size : 50mlIngredients : Metoclopramide (HCl):5mg/5mlGeneric Category : Antiemetics & antinauseants

    Reviews

    There are no reviews yet.

    Be the first to review “PLASIL 5mg|5ml Syrup 50ml”

    How it works

    PLASIL 5mg|5ml Syrup 50ml works by blocking a natural substance (dopamine). It speeds up stomach emptying and movement of the upper intestines.

    Side effects

    Major & minor side effects for PLASIL 5mg|5ml Syrup 50ml

    • Dizziness and Drowsiness
    • Abdominal pain
    • Muscle pain and weakness
    • Headache
    • Skin rash
    • Irregular heartbeat
    • Diarrhea
    • Restlessness
    • Lack or loss of strength
    • Difficulty in breathing
    • Pain at injection site

    Uses of PLASIL 5mg|5ml Syrup 50ml

    What is it prescribed for?

    • Chemotherapy induced nausea and vomiting

      This medicine is used to treat nausea and vomiting associated with the use of chemotherapy medicines for the treatment of cancer.

    • Gastroparesis

      This medicine is used in the treatment of gastroparesis (slow stomach emptying) in diabetic patients, since it increases the gastric emptying and prevents nausea and vomiting.

    • Small Intestine Intubation

      This medicine is used as an aid to facilitate small bowel intubation in patients whom the tube does not pass the pylorus with conventional means.

    • Radiological examination

      This medicine is used as an aid in radiological examination of the stomach and/or small intestine to stimulate the gastric emptying and intestinal transit.

    Concerns

    Frequently asked questions

    • Onset of action

      The effect of this medicine can be observed within 1 to 3 minutes after the intravenous administration and within 10 to 15 minutes after the intramuscular administration of the dose.

    • Duration of Effect

      The effect of this medicine lasts for an average duration of 1 to 2 hours.

    • Safe with Alchohol?

      Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of nervous system side effects such as dizziness, drowsiness, and difficulty concentrating. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

    • Is it habit forming?

      No habit forming tendency has been reported.

    • Usage in pregnancy?

      This medicine is recommended for use in pregnant women only if necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

    • Usage while breast-feeding?

      This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

    When not to use?

    • Allergy

      This medicine is not recommended for use in patients with a known allergy to PLASIL 5mg|5ml Syrup 50ml or any other inactive ingredients present in the formulation.

    • Gastrointestinal disorders

      This medicine is not recommended for use in patients with gastrointestinal disorders like gastrointestinal hemorrhage, mechanical obstruction, and gastrointestinal perforation due to the increased risk of worsening of the patient's condition.

    • Epilepsy

      This medicine is not recommended for use in patients with epilepsy due to the increased risk of worsening of the patient's condition.

    • Pheochromocytoma

      This medicine is not recommended for use in patients with conditions like pheochromocytoma due to an increase in the risk of hypertensive crisis (very severe increase in the blood pressure).

    Warnings

    Warnings for special population
    • Pregnancy

      This medicine is recommended for use in pregnant women only if necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

    • Breast-feeding

      This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

    General Warnings
    • Neuroleptic Malignant Syndrome (NMS)

      Use of this medicine may cause Neuroleptic Malignant Syndrome which is characterized by hyperthermia (fever), muscle rigidity, and altered consciousness. Report to the doctor immediately if these symptoms appear. Discontinue the treatment with this medicine if the symptoms persist.

    • Depression

      Use of this medicine may cause depression in patients with or without the prior history of depression. Any symptoms of change in behavior or suicidal thoughts should be informed to the doctor on priority. Discontinue the treatment with this medicine if the symptoms worsen.

    • Kidney impairment

      This medicine should be used with extreme caution in patients suffering from kidney function impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • Liver impairment

      This medicine should be used with extreme caution in patients suffering from liver function impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • Driving or operating machinery

      Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during or immediately after treatment with this medicine.

    Dosage

    • Missed Dose

      Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

    • Overdose

      Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

    Interactions

    Interaction with Medicines
    • Phenytoin moderate
    • Atropine moderate
    • Chlorpromazine severe
    • Promethazine severe
    Disease interactions
    • severe

      This medicine is not recommended for use in patients with gastrointestinal disorders like mechanical bowel obstruction, bowel perforation, or gastrointestinal hemorrhage due to the increased risk of worsening of the patient's condition. An alternative treatment option should be considered based on the clinical condition.

    • moderate

      This medicine should be used with caution in patients with Parkinson's disease due to an increase in the risk of parkinsonian-like symptoms such as akinesia, bradykinesia, tremors, pill-rolling motion, and postural abnormalities. These symptoms will usually appear within the first 6 months of the treatment and subside within 2 to 3 months after discontinuation of the treatment.

    General Instructions

    This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

    References

    Additional Information>

    One of the following licensed pharmacy from the nearest location will deliver PLASIL 5mg|5ml Syrup 50ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

    Questions and Answers

    There are no questions yet. Be the first to ask a question about this product.

    Only registered users are eligible to enter questions

    Authentic

    Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.

    Affordable

    We work hard to bring you unimaginable discounts without compromising on quality.

    Secure

    We uses SSL (standard security technology) to ensure data privacy of all our customers.

    We operate as a licensed pharmacy in Pakistan with License No. 2420

    Customer Service available Mon - Sat 10am - 6pm

    Medicalstore.com.pk © All rights reserved

    Made with ❤ by Dairah